CATALOGO DEI PRODOTTI DELLA RICERCA

ZANOTTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.887
EU - Europa 4.656
AS - Asia 3.337
SA - Sud America 382
AF - Africa 79
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.814
RU - Federazione Russa 1.647
SG - Singapore 1.223
CN - Cina 1.186
GB - Regno Unito 1.106
IT - Italia 376
SE - Svezia 347
VN - Vietnam 303
BR - Brasile 286
DE - Germania 272
HK - Hong Kong 245
FR - Francia 234
IE - Irlanda 207
FI - Finlandia 199
KR - Corea 98
UA - Ucraina 54
IN - India 48
NL - Olanda 48
CA - Canada 44
TR - Turchia 36
BD - Bangladesh 34
BE - Belgio 33
AR - Argentina 32
JP - Giappone 32
ID - Indonesia 28
PL - Polonia 27
ES - Italia 23
ZA - Sudafrica 21
AT - Austria 19
MX - Messico 19
NG - Nigeria 19
AU - Australia 16
EC - Ecuador 14
IQ - Iraq 14
UZ - Uzbekistan 13
CL - Cile 12
VE - Venezuela 12
PK - Pakistan 10
CO - Colombia 9
MA - Marocco 9
LT - Lituania 8
CH - Svizzera 7
MY - Malesia 7
CZ - Repubblica Ceca 6
DK - Danimarca 6
IR - Iran 6
RO - Romania 6
TN - Tunisia 6
AZ - Azerbaigian 5
BO - Bolivia 5
GR - Grecia 5
PE - Perù 5
PY - Paraguay 5
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
PT - Portogallo 4
SI - Slovenia 4
BJ - Benin 3
CR - Costa Rica 3
HR - Croazia 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CG - Congo 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
KH - Cambogia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BT - Bhutan 1
CD - Congo 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
Totale 13.349
Salva come PNG Salva come JPEG
Città #
Southend 928
Singapore 644
Moscow 570
Ashburn 551
Chandler 511
San Jose 407
Dallas 402
Jacksonville 320
Woodbridge 304
Ann Arbor 293
Beijing 283
Hong Kong 243
Dublin 205
Houston 162
The Dalles 155
New York 134
Verona 132
Wilmington 106
Jinan 88
Ho Chi Minh City 85
Los Angeles 81
Lawrence 80
Princeton 80
Hanoi 73
Nanjing 65
Munich 58
Helsinki 57
Shenyang 55
Tianjin 41
Bologna 39
Hebei 39
Columbus 36
São Paulo 36
Buffalo 34
Ningbo 34
Brussels 33
Zhengzhou 31
Changsha 29
Hangzhou 29
Taizhou 29
Tokyo 29
Boardman 28
Haikou 28
Guangzhou 27
Santa Clara 27
Redondo Beach 26
Manchester 25
Milan 25
Turku 24
Chicago 22
Denver 22
Warsaw 22
Chennai 21
Groningen 21
Nanchang 21
Sindelfingen 21
Frankfurt am Main 19
Seattle 18
Jiaxing 17
Montreal 17
Norwalk 17
Orem 16
Stockholm 16
Taiyuan 16
Dearborn 15
London 15
Redwood City 15
Seoul 15
Vienna 15
Abuja 14
Atlanta 14
Haiphong 14
Johannesburg 14
Falls Church 13
Phoenix 13
Boston 12
Lancaster 12
San Francisco 12
Tashkent 12
Amsterdam 11
Brooklyn 11
Council Bluffs 11
Dong Ket 11
Falkenstein 11
Jakarta 11
Rome 11
Fuzhou 10
Lanzhou 10
Poplar 10
Augusta 9
Biên Hòa 9
Mexico City 9
Toronto 9
Belo Horizonte 8
Düsseldorf 8
Fairfield 8
Redmond 8
Rio de Janeiro 8
Washington 8
Charlotte 7
Totale 8.410
Salva come PNG Salva come JPEG
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 330
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 259
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 256
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 251
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 248
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 247
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 224
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 224
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
BCR-signaling profiles associated with prognosis and progression in B-CLL 221
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 219
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 215
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 214
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 213
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 212
BCR-signaling profiles associated with prognosis and progression in B-CLL 211
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 205
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 204
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 203
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 202
Bone involvement and osteoporosis in mastocytosis. 200
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 198
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 198
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 189
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 188
Bone involvement in patient with clonal mast cell disorders 186
The high oxygen affinity haemoglobin Nantes: a family case description 185
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 183
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 180
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 180
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 179
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 174
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 171
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 168
Underdiagnosed systemic mastocytosis: The role of flow cytometry 166
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 166
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 164
Bone Disease in Mastocytosis 164
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 162
Effects of denosumab on peripheral lymphocyte subpopulations 160
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 158
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 156
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 156
Prevalence of osteoporosis in patients affected by mastocytosis 156
Vaccination Management In Children and Adults With Mastocytosis 156
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 153
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 151
Osteopetrosi 149
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 148
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 148
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 145
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 143
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 143
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 142
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 139
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 138
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 132
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 132
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 131
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 131
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 130
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 130
Single Cell Network Profiling (SCNP) assay reveals B Cell Receptor Signaling heterogeneity in the Context of ZAP-70 Expression in patients with Chronic Lymphocytic Leukemia (CLL) 128
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 125
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 122
Mast Cell Disorders In Drug Hypersensitivity 121
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 118
Mastocytosis and allergic diseases 116
Hymenoptera Allergy and Mast Cell Activation Syndromes 112
Systemic Mastocytosis 106
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 106
Mastocytosis and insect venom allergy 101
Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. 100
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 94
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 93
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 92
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 90
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study 71
Night shift work and lymphoma: results from an Italian multicentre case-control study 70
Letter to the Editor: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis 61
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 49
null 44
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 29
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 21
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study 20
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM 1
Totale 13.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.824
article - articoli 28.568
book - libri 0
conference - conferenze 12.256
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 10 156 37
2021/2022744 55 237 8 91 42 19 21 42 35 22 39 133
2022/20231.442 92 170 114 292 92 362 30 76 163 10 26 15
2023/2024773 57 66 47 69 88 132 37 71 5 39 123 39
2024/20251.771 85 126 98 300 80 47 78 62 287 124 160 324
2025/20265.294 379 301 405 897 1.362 376 508 276 444 346 0 0
Totale 13.464